Excretable, ultrasmall hexagonal NaGdF 4 :Yb50% nanoparticles for bimodal imaging and radiosensitization

ConclusionThese biocompatible and in vivo clearable ultrasmall NaGdF4:Yb50% are promising candidates for further evaluation in image-guided radiotherapy applications.

Source: Cancer Nanotechnology - February 5, 2021 Category: Cancer & Oncology Source Type: research